KIF9 anticorps (N-Term)
-
- Antigène Voir toutes KIF9 Anticorps
- KIF9 (Kinesin Family Member 9 (KIF9))
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp KIF9 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- KIF9 antibody was raised against the n terminal of KIF9
- Purification
- Affinity purified
- Immunogène
- KIF9 antibody was raised using the N terminal of KIF9 corresponding to a region with amino acids MGTRKKVHAFVRVKPTDDFAHEMIRYGDDKRSIDIHLKKDIRRGVVNNQQ
- Top Product
- Discover our top product KIF9 Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
KIF9 Blocking Peptide, catalog no. 33R-6083, is also available for use as a blocking control in assays to test for specificity of this KIF9 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KIF9 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- KIF9 (Kinesin Family Member 9 (KIF9))
- Autre désignation
- KIF9 (KIF9 Produits)
- Synonymes
- anticorps RGD1565187, anticorps si:dkey-86l18.8, anticorps kinesin family member 9, anticorps si:dkey-86l18.8, anticorps KIF9, anticorps Kif9
- Sujet
- KIF9 acts as a regulator of podosomes and of podosomal matrix degradation in primary human macrophages.
- Poids moléculaire
- 90 kDa (MW of target protein)
-